EW
Edwards Lifesciences Corp.
$79.96
-3.38%
2026-05-08
About Edwards Lifesciences Corp.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Key Fundamentals
P/E Ratio
44.42
Forward P/E
24.44
EPS (TTM)
$1.85
ROE
10.4%
Revenue Growth (YoY)
16.7%
Profit Margin
17.4%
Debt/Equity
6.82
Price/Book
4.62
Beta
0.87
Market Cap
$47.32B
Avg Volume (10D)
5.8M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$87.32
60D Low
$75.83
Avg Volume
4.1M
Latest Close
$79.96
Get breakout alerts for EW
Sign up for Breakout Scanner to receive daily notifications when EW triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Edwards Lifesciences Corp. (EW) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors EW daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. EW operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.